Cargando…
Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
Posttransplant lymphoproliferative disorder (PTLD) is a frequent complication of intestinal transplantation and is associated with a poor prognosis. There is currently no consensus on optimal therapy. Recurrent PTLD involving the central nervous system (CNS) represents a particularly difficult thera...
Autores principales: | Twist, Clare J., Castillo, Ricardo O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747408/ https://www.ncbi.nlm.nih.gov/pubmed/23984169 http://dx.doi.org/10.1155/2013/765230 |
Ejemplares similares
-
Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012) -
Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report
por: Gao, Rupan, et al.
Publicado: (2021) -
Methotrexate-associated lymphoproliferative disorders in the central nervous system and stomach: A case report
por: Kawazoe, Mai, et al.
Publicado: (2020) -
Successful Treatment of Central Nervous System Post-Transplant Lymphoproliferative Disease With a Reduced Dose of High-Dose Methotrexate
por: Albusoul, Linda, et al.
Publicado: (2022) -
Recurrent, Multisubtype Posttransplant Lymphoproliferative Disorder Masquerading as Inflammatory Bowel Disease
por: Mussarat, Saad, et al.
Publicado: (2022)